Not a good buy right now: the primary trend is bearish (SMA_200 > SMA_20 > SMA_5) and there are no Intellectia buy signals to justify an impatient entry.
Pre-market at ~0.90 is trading below the first support (S1 0.916), which increases the odds of further downside toward S2 (0.802) before any sustainable bounce.
Fundamentals are weakening (revenue down YoY, losses widened), and there are no near-term news catalysts.
Technical Analysis
Trend: Bearish structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), signaling a downtrend.
Momentum: MACD histogram is positive (0.00888) and expanding, suggesting a developing rebound attempt, but it is not yet enough to reverse the broader downtrend.
RSI (6): ~31, near oversold/low-neutral—supports a potential short-term bounce, but not a high-conviction trend change.
Key levels: Pivot 1.099; Resistance R1 1.282 / R2 1.396; Support S1 0.916 / S2 0.802. With price ~0.90, BRLS is slipping under S1.
Pattern-based odds: Similar-pattern stats indicate 60% chance of -1.22% next day; upside probabilities appear higher over 1 week/month (shown as +18.06% / +28.72%), but near-term downside risk dominates given the broken support.
in pre-market, increasing risk of a move toward S2 (0.802).
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 7.10M, down -7.60% YoY (top-line contraction).
Net income: -3.78M, down -21.76% YoY (losses widened).
EPS: -0.18, down -21.74% YoY.
Gross margin: 14.65%, down -11.53% YoY (profitability pressure).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data provided, so there is no clear Wall Street consensus trend to lean on.
Wall Street pros/cons (based only on provided data): Pros—possible technical mean-reversion bounce from depressed levels; Cons—deteriorating YoY financials and a confirmed bearish trend without fresh catalysts.
Wall Street analysts forecast BRLS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRLS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast BRLS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRLS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
